Table 4.
Sub-analysis of each tendency’s regression modeling interaction for prolonged delirium/coma days
| Multivariate model 5 OR (95% CI)a | VIF | |
|---|---|---|
| EuroSCOREII | 1.1 (0.9–1.3) | 1.3 |
| MMSE | 0.9 (0.9–1.1) | 1.1 |
| Negative Affectivity (NA)b | 1.0 (1.0–1.1)* | 2.5 |
| Social Inhibition (SI)b | 1.0(0.9–1.0) | 1.8 |
| Negative Affectivity (NA) × Social Inhibition (SI) | 0.9(0.9–1.0) | 1.7 |
| Depressive symptomsc | 1.1 (1.0–1.3)* | 1.1 |
| Aortic clamping time | 0.9 (0.9–1.0) | 1.0 |
| mSOFAd | 1.7 (1.3–2.2)* | 1.6 |
| Benzodiazepinee | 11 (2.6–46.2)* | 1.0 |
| Propofole | 1.1(1.0–1.2)* | 1.8 |
| Dexmedetomidinef | 1.1(0.9–1.3) | 1.7 |
a: P values obtained from Ordered Logistic Regression *P value<0.05
b: Centering was performed
c: measured by Hospital Anxiety and Depression Scale (HADS)
d: Exclude GCS, used average of 7 days
e: Used average of 7 days. mg/day/kg
f: Used average of 7 days. μg/day/kg
MMSE mini-mental state examination, EuroSCOREII European System for Cardiac Operative Risk Evaluation II, mSOFA modified Sequential Organ Failure Assessment